ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,391Medicare Part D Prescriptions Filled, Including Refills

Rank: 190 out of 617

$410K Total Retail Price of All Prescriptions

Rank: 148 out of 617

380 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,649 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 316 293 1 1
SIMVASTATIN 284 244 2 2
ENALAPRIL MALEATE 247 195 3 34
OMEPRAZOLE 221 209 4 3
AMLODIPINE BESYLATE 197 191 5 6
METFORMIN HCL 189 172 6 9
WARFARIN SODIUM 158 150 7 7
FUROSEMIDE 149 148 8 4
HYDROCODONE-ACETAMINOPHEN 141 123 S3 9 8
SERTRALINE HCL 115 108 10 20
POTASSIUM CHLORIDE 113 106 11 10
TRAMADOL HCL 111 108 12 15
HYDROCHLOROTHIAZIDE 103 102 13 13
ALENDRONATE SODIUM 93 93 14 25
ATORVASTATIN CALCIUM 89 89 15 14
METOPROLOL TARTRATE 83 76 16 11
METOPROLOL SUCCINATE 79 68 17 12
LANTUS 77 73 18 39
CARVEDILOL 75 75 19 19
ATENOLOL 74 74 20 17
ENALAPRIL-HYDROCHLOROTHIAZIDE 73 73 21 183
RANITIDINE HCL 73 70 21 40
TAMSULOSIN HCL 70 54 23 26
NAMENDA 69 43 24 35
CRESTOR 66 64 25 28
ISOSORBIDE MONONITRATE ER 64 64 26 52
DONEPEZIL HCL 63 51 27 30
LISINOPRIL 62 60 28 5
BYSTOLIC 57 53 29 64
ALLOPURINOL 57 57 29 27
DILTIAZEM ER 57 56 29 81
PREDNISONE 56 50 32 31
GLIMEPIRIDE 55 55 33 33
TRIAMTERENE-HCTZ 54 42 34 47
CEFDINIR 54 48 34 169
ADVAIR DISKUS 54 51 34 38
FENTANYL 54 31 S2 34 45
TRICOR 50 30 38 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.